Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/9293
Title: Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion
Authors: Motbey, CP
Karanges, E
Li, KM
Wilkinson, S
Winstock, AR
Ramsey, J
Hicks, C
Kendig, MD
Wyatt, NA
Callaghan, PD
McGregor, IS
Keywords: Rats
Drugs
Serotonin
Dopamine
Inflammation
Bioelectricity
Cocaine
Analeptics
Brain
Issue Date: 18-Sep-2012
Publisher: PLOS
Citation: Motbey, C. P., Karanges, E., Li, K. M., Wilkinson, S., Winstock, A. R., Ramsey, J., Hicks, C., Kendig, M. D., Wyatt, N., Callaghan, P. D., & McGregor, I. S. (2012). Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. PloS one, 7(9), e45473. doi:10.1371/journal.pone.0045473
Abstract: Mephedrone (4-methylmethcathinone, MMC) is a popular recreational drug, yet its potential harms are yet to be fully established. The current study examined the impact of single or repeated MMC exposure on various neurochemical and behavioral measures in rats. In Experiment 1 male adolescent Wistar rats received single or repeated (once a day for 10 days) injections of MMC (30 mg/kg) or the comparator drug methamphetamine (METH, 2.5 mg/kg). Both MMC and METH caused robust hyperactivity in the 1 h following injection although this effect did not tend to sensitize with repeated treatment. Striatal dopamine (DA) levels were increased 1 h following either METH or MMC while striatal and hippocampal serotonin (5-HT) levels were decreased 1 h following MMC but not METH. MMC caused greater increases in 5-HT metabolism and greater reductions in DA metabolism in rats that had been previously exposed to MMC. Autoradiographic analysis showed no signs of neuroinflammation ([125I]CLINDE ligand used as a marker for translocator protein (TSPO) expression) with repeated exposure to either MMC or METH. In Experiment 2, rats received repeated MMC (7.5, 15 or 30 mg/kg once a day for 10 days) and were examined for residual behavioral effects following treatment. Repeated high (30 mg/kg) dose MMC produced impaired novel object recognition 5 weeks after drug treatment. However, no residual changes in 5-HT or DA tissue levels were observed at 7 weeks post-treatment. Overall these results show that MMC causes acute but not lasting changes in DA and 5-HT tissue concentrations. MMC can also cause long-term memory impairment. Future studies of cognitive function in MMC users are clearly warranted. © 2012 Motbey et al.
Gov't Doc #: 8826
URI: https://doi.org/10.1371/journal.pone.0045473
http://apo.ansto.gov.au/dspace/handle/10238/9293
ISSN: 1932-6203
Appears in Collections:Journal Articles

Files in This Item:
File Description SizeFormat 
journal.pone.0045473.PDF663.85 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.